199 related articles for article (PubMed ID: 1813016)
1. Proliferation of peripheral lymphocytes to interleukin-2 and interleukin-4 after marrow transplantation.
Klingemann HG; Kohn FR; Phillips GL
Eur Cytokine Netw; 1991; 2(2):131-6. PubMed ID: 1813016
[TBL] [Abstract][Full Text] [Related]
2. Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients.
Lum LG; Joshi ID; Galoforo SC; Abella E; Karanes C; Ratanatharathorn V; Schultz KR; Uberti JP; Sensenbrenner LL; Ledbetter JA
Bone Marrow Transplant; 1993 Dec; 12(6):565-71. PubMed ID: 8136739
[TBL] [Abstract][Full Text] [Related]
3. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
[TBL] [Abstract][Full Text] [Related]
4. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
[TBL] [Abstract][Full Text] [Related]
5. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
Kedar E; Or R; Naparstek E; Zeira E; Slavin S
Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477
[TBL] [Abstract][Full Text] [Related]
6. Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact.
Lum LG; Joshi ID; Smith MR; Ratanatharathorn V; Galoforo SC; Karanes C; Uberti JP; Sensenbrenner LL
Bone Marrow Transplant; 1994 Feb; 13(2):187-95. PubMed ID: 8205088
[TBL] [Abstract][Full Text] [Related]
7. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
8. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
9. IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.
Levy RB; Jones M; Hamilton BL; Paupe J; Horowitz T; Riley R
J Immunol; 1995 Jan; 154(1):106-15. PubMed ID: 7995931
[TBL] [Abstract][Full Text] [Related]
10. Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation.
Mitsuyasu RT; Li SN; Champlin RE; Gale RP
Exp Hematol; 1986 Dec; 14(11):1049-55. PubMed ID: 3536545
[TBL] [Abstract][Full Text] [Related]
11. Generation of CD8 cytolytic T cells early after autologous or allogeneic bone marrow transplantation.
Charmot D; Ragueneau M; Olive D; Maraninchi D; Mawas C
Bone Marrow Transplant; 1987 Aug; 2(2):183-94. PubMed ID: 2901879
[TBL] [Abstract][Full Text] [Related]
12. Promotion of human T lymphocyte proliferation by IL-4.
Mitchell LC; Davis LS; Lipsky PE
J Immunol; 1989 Mar; 142(5):1548-57. PubMed ID: 2783946
[TBL] [Abstract][Full Text] [Related]
13. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
[TBL] [Abstract][Full Text] [Related]
14. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Leblanc P; Symann ML
Cancer Res; 1994 Jul; 54(14):3800-7. PubMed ID: 7913409
[TBL] [Abstract][Full Text] [Related]
15. Humoral immunodeficiency in patients after bone marrow transplantation.
Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Mauz-Körholz C; Zintl F; Burdach S
Bone Marrow Transplant; 1996 Dec; 18(6):1123-30. PubMed ID: 8971382
[TBL] [Abstract][Full Text] [Related]
16. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
Jun HX; Jun CY; Yu ZX
Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
[TBL] [Abstract][Full Text] [Related]
17. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation.
Rojas B; Cuhna R; Zafirakis P; Ramirez JM; Lizan-garciía M; Zhao T; Foster CS
Exp Eye Res; 2005 Sep; 81(3):313-25. PubMed ID: 16129099
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
19. The role of interleukin-2 in proliferative responses in vitro of T cells from patients after bone marrow transplantation. Evidence that minor defects can lead to in vitro unresponsiveness.
Roosnek EE; Brouwer MC; Vossen JM; Roos MT; Schellekens PT; Zeijlemaker WP; Aarden LA
Transplantation; 1987 Jun; 43(6):855-60. PubMed ID: 3296352
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor).
Gately MK; Desai BB; Wolitzky AG; Quinn PM; Dwyer CM; Podlaski FJ; Familletti PC; Sinigaglia F; Chizonnite R; Gubler U
J Immunol; 1991 Aug; 147(3):874-82. PubMed ID: 1713608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
